Source: Eur Respir J 2004; 24 : 728-730
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Schwarz C., Lubbert H., Rahn W., Schonfeld N., Serke M., Loddenkemper R.. Medical thoracoscopy: hormone receptor content in pleural metastases due to breast cancer. Eur Respir J 2004; 24 : 728-730

Member's Comments

No comment yet.

Related content which might interest you: Identification of hormone receptors and HER-2 in samples of mediastinal nodal metastases of breast carcinoma obtained through endobronchial ultrasound Source: Annual Congress 2013 –TBNA, EBUS-TBNA and new technologies for diagnostic bronchoscopy Year: 2013 68Ga-DOTA-NT-20.3. An innovative probe for neurotensin receptor-positive tumor imaging in the diagnosis of malignant pleural mesothelioma Source: International Congress 2018 – Pleural disease: diagnosis, monitoring and management Year: 2018 An update on treatment of malignant pleural effusion with or without known primary bronchial adenocarcinoma Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis Year: 2006 Thoracoscopy in malignant pleural effusions secondary to breast cancer Source: Eur Respir J 2006; 28: Suppl. 50, 611s Year: 2006 Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients Source: Eur Respir J 2011; 38: 1425-1430 Year: 2011 Epidemiology and clinical problems of orphant pleural adenocarcinoma Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis Year: 2006 Clinical and biological prognostic factors in malignant pleural effusion (MPE) secondary to breast cancer Source: Annual Congress 2005 - What's new in the pleura Year: 2005 RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer Source: Eur Respir J 2012; 39: 677-684 Year: 2012 Biochemical and cytological features of metastatic pleural effusions in breast cancer Source: Eur Respir J 2007; 30: Suppl. 51, 671s Year: 2007 Surgery for lung cancer with pleural effusion Source: Eur Respir J 2002; 20: Suppl. 38, 180s Year: 2002 The utility of survivin mRNA as a diagnostic biomarker in lung cancer with malignant pleural effusion Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions Year: 2013 Pleural effusion in cases of breast carcinoma Source: Eur Respir J 2003; 22: Suppl. 45, 62s Year: 2003 Diagnostic thoracoscopy in patients with lung cancer and pleural effusion Source: Annual Congress 2007 - Pleural techniques and diagnosis of peripheral lung nodules Year: 2007 Ultra-late pleural metastasis of breast cancer: are they so rare? Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction Year: 2021 Survival of lung adenocarcinoma patients with malignant pleural effusion Source: Eur Respir J 2013; 41: 1409-1418 Year: 2013 Medical thoracoscopy for diagnosis of pleural effusion in cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 528s Year: 2004 Malignant pleural mesothelioma: new treatment modalities Source: Annual Congress 2005 - Clinical year in review Year: 2005 The role of diagnostic thoracoscopy in patients with lung cancer and pleural effusion Source: Eur Respir J 2003; 22: Suppl. 45, 542s Year: 2003 Diagnostic utility of cell block method combined with conventional smear cytology in the diagnosis of exudative pleural effusions accompanying lung cancer Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases Year: 2013 Pleural mesothelioma with solitary simultaneous subcutaneous tissue metastasis of the abdominal wall at diagnosis - First clinical documentation Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013